Headline RoundupOctober 23rd, 2020

Antiviral Drug Remdesivir Approved as COVID-19 Treatment by FDA

AllSides Summary

The Food and Drug Administration (FDA) approved remdesivir, an antiviral drug from Gilead Sciences, as a treatment for COVID-19 Thursday. The drug, sold under the name Veklury, will be used for hospitalized COVID-19 patients. Previously authorized by the FDA for emergency use to treat COVID-19, it has become the first FDA-approved treatment for the virus. Typically administered in five doses through an IV, remdesivir has shown to shorten recovery time by working to stop replication of SARS-CoV-2, the virus that causes COVID-19. However, a World Health Organization (WHO) study has found that four drugs, including remdesivir, have no effect in curing the virus. President Donald Trump was administered remdesivir along with several other drugs during his bout with the virus earlier this month. The news has been covered similarly by outlets from across the political spectrum.

Featured Coverage of this Story

More headline roundups

More News about Coronavirus from the Left, Center and Right

From the Left

From the Center

From the Right